The9 (NCTY) Stock Price, News & Analysis

The9's stock was trading at $7.49 at the beginning of the year. Since then, NCTY stock has decreased by 19.1% and is now trading at $6.06.
View the best growth stocks for 2024 here.

The9 saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 65,200 shares, a drop of 20.0% from the March 15th total of 81,500 shares. Based on an average trading volume of 60,000 shares, the short-interest ratio is presently 1.1 days. Currently, 2.3% of the company's stock are sold short.
View The9's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our NCTY earnings forecast.

Shares of The9 reverse split on the morning of Monday, October 2nd 2023. The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other The9 investors own include Amarin (AMRN), Gevo (GEVO), Biocept (BIOC), Nabriva Therapeutics (NBRV), Occidental Petroleum (OXY), Acasti Pharma (ACST), Anavex Life Sciences (AVXL), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT) and Jaguar Health (JAGX).

Shares of NCTY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.